Samantha McLemore - Patient Capital Management
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
← All TEVA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | 0 | 0.00 | Sell 100.00% | 0.10 | $12.47–17.75 · VW $15.24i | SEC | |
| 2024 Q4 | 100,000 | 0.10 | $22.04 | $2,204,000 | SEC | ||
| 2024 Q3 | 100,000 | 0.09 | $18.02 | $1,802,000 | SEC | ||
| 2024 Q2 | 100,000 | 0.09 | $16.25 | $1,625,000 | SEC | ||
| 2024 Q1 | 100,000 | 0.07 | $14.11 | $1,411,000 | SEC | ||
| 2023 Q4 | 100,000 | 0.06 | Reduce 20.00% | 0.02 | $8.55–12.64 · VW $11.10i | $1,044,000 | SEC |
| 2023 Q3 | 125,000 | 0.08 | Reduce 59.16% | 0.08 | $8.06–10.72 · VW $9.12i | $1,275,000 | SEC |
| 2023 Q2 | 306,054 | 0.13 | Reduce 51.11% | 1.27 | $7.09–9.21 · VW $8.23i | $2,304,583 | SEC |
| 2023 Q1 | 626,000 | 2.49 | Reduce 24.81% | 0.93 | $8.10–10.96 · VW $9.26i | $5,540,100 | SEC |
| 2022 Q4 | 832,575 | 3.75 | Reduce 29.14% | 1.40 | $7.95–11.45 · VW $9.98i | $7,593,084 | SEC |
| 2022 Q3 | 1,175,000 | 4.81 | Reduce 1.50% | 0.07 | $7.64–11.34 · VW $9.30i | $9,482,000 | SEC |
| 2022 Q2 | 1,192,950 | 4.40 | Add 19.19% | 0.71 | $6.78–9.72 · VW $8.63i | $8,971,000 | SEC |
| 2022 Q1 | 1,000,850 | 3.71 | Add 33.46% | 0.93 | $7.24–10.50 · VW $8.82i | $9,398,000 | SEC |
| 2021 Q4 | 749,900 | 2.43 | $8.01 | $6,007,000 | SEC |
Price snapshot:
Current price$32.18
52-week low$14.99
52-week high$37.35